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Background
The performance of the Beta Binomial (BB) model is
compared with several existing models for mapping the
QLQC-30 on to the EQ-5D using data from lung cancer
trials.
Methods
Data from 2 separate non-small cell lung cancer clini-
cal trials (TOPICAL and SOCCAR) are used to develop
and validate the BB model. Comparisons with Linear,
TOBIT, Quantile, Quadratic and CLAD models were
carried out. The mean prediction error, R2, proportion
predicted outside the valid range, clinical interpretation
of coefficients, model fit and estimation of Quality
Adjusted Life Years (QALY) are reported and com-
pared. Monte-Carlo simulation from mixture distribu-
tions was performed to assess the performance of the
models.
Results
The Beta-Binomial regression model performed ‘best’
among all models. Estimates from the BB were more
accurate for predicting EQ-5D and QALYs compared to
other modelling approaches. Mean difference in QALYs
(predicted vs. observed) were 0.053 vs. 0.051 for TOPI-
CAL and 0.162 vs. 0.164 for SOCCAR. Simulated 95%
confidence intervals showed that the BB model con-
tained the observed mean more often compared to the
other models. All algorithms over-predict at poorer
health states but the BB model was relatively better, par-
ticularly for the SOCCAR data.
Conclusion
The Beta Binomial regression may offer superior predic-
tive properties compared to existing algorithms and could
be a more appropriate algorithm to map the relationship
between the EQ-5D and QLQC-30. Future models could
include toxicity data jointly with EQ-5D to improve pre-
diction at poorer health states. The generalized lambda
distribution may offer a way to simulate from a mixture
distribution.
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